Novel lead generation through hypothetical pharmacophore three-dimensional database searching:: Discovery of isoflavonoids as nonsteroidal inhibitors of rat 5α-reductase

被引:36
作者
Chen, GS
Chang, CS
Kan, WM
Chang, CL
Wang, KC
Chern, JW
机构
[1] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan
关键词
D O I
10.1021/jm010433s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A hypothetical pharmacophore of 5 alpha -reductase inhibitors was generated and served as a template in virtual screening. When the pharmacophore was used, eight isoflavone derivatives were characterized as novel potential nonsteroidal inhibitors of rat 5 alpha -reductase. This investigation has demonstrated a practical approach toward the development of lead compounds through a hypothetic pharmacophore via three-dimensional database searching.
引用
收藏
页码:3759 / 3763
页数:5
相关论文
共 23 条
  • [1] ANDERSSON S, 1989, J BIOL CHEM, V264, P16249
  • [2] 4-AZA-3-OXO-5-ALPHA-ANDROST-1-ENE-17-BETA-N-ARYL-CARBOXAMIDES AS DUAL INHIBITORS OF HUMAN TYPE-1 AND TYPE-2 STEROID 5-ALPHA-REDUCTASES - DRAMATIC EFFECT OF N-ARYL SUBSTITUENTS ON TYPE-1 AND TYPE-2 5-ALPHA-REDUCTASE INHIBITORY POTENCY
    BAKSHI, RK
    RASMUSSON, GH
    PATEL, GF
    MOSLEY, RT
    CHANG, B
    ELLSWORTH, K
    HARRIS, GS
    TOLMAN, RL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) : 3189 - 3192
  • [3] MOLECULAR MODELING SOFTWARE AND METHODS FOR MEDICINAL CHEMISTRY .2.
    COHEN, NC
    BLANEY, JM
    HUMBLET, C
    GUND, P
    BARRY, DC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) : 883 - 894
  • [4] INHIBITION OF 5-ALPHA-REDUCTASE IN GENITAL SKIN FIBROBLASTS AND PROSTATE TISSUE BY DIETARY LIGNANS AND ISOFLAVONOIDS
    EVANS, BAJ
    GRIFFITHS, K
    MORTON, MS
    [J]. JOURNAL OF ENDOCRINOLOGY, 1995, 147 (02) : 295 - 302
  • [5] STRUCTURE-ACTIVITY-RELATIONSHIPS FOR INHIBITION OF TYPE-1 AND TYPE-2 HUMAN 5-ALPHA-REDUCTASE AND HUMAN ADRENAL 3-BETA-HYDROXY-DELTA(5)-STEROID DEHYDROGENASE 3-KETO-DELTA(5)-STEROID ISOMERASE BY 6-AZAANDROST-4-EN-3-ONES - OPTIMIZATION OF THE C17 SUBSTITUENT
    FRYE, SV
    HAFFNER, CD
    MALONEY, PR
    HINER, RN
    DORSEY, GF
    NOE, RA
    UNWALLA, RJ
    BATCHELOR, KW
    BRAMSON, HN
    STUART, JD
    SCHWEIKER, SL
    VANARNOLD, J
    BICKETT, DM
    MOSS, ML
    TIAN, GC
    LEE, FW
    TIPPIN, TK
    JAMES, MK
    GRIZZLE, MK
    LONG, JE
    CROOM, DK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) : 2621 - 2627
  • [6] 19-nor-10-azasteroids, a new class of steroid 5 alpha-reductase inhibitors .2. X-ray structure, molecular modeling, conformational analysis of 19-nor-10-azasteroids and comparison with 4-azasteroids and 6-azasteroids
    Guarna, A
    Occhiato, EG
    Machetti, F
    Marrucci, A
    Danza, G
    Serio, M
    Paoli, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (21) : 3466 - 3477
  • [7] HOLT KG, 1993, PHYS THER PRACT, V2, P1
  • [8] Igarashi S, 2000, CHEM PHARM BULL, V48, P382
  • [9] Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods
    Kaminski, JJ
    Rane, DF
    Snow, ME
    Weber, L
    Rothofsky, ML
    Anderson, SD
    Lin, SL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (25) : 4103 - 4112
  • [10] Pharmacological options in the treatment of benign prostatic hyperplasia
    Kenny, B
    Ballard, S
    Blagg, J
    Fox, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) : 1293 - 1315